NIPH Clinical Trials Search

UMIN ID: UMIN000002329

Registered date:18/08/2009

Study on preoperative concurrent chemoradiotherapy with S-1 in oral cancer (Phase II study)

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedOral cancer
Date of first enrollment2009/08/01
Target sample size15
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)The total 40Gy of irradiation is delivered to both primary site and metastasized neck region. Chemotherapy regimen consisted of 5-day S-1 consecutive administration, followed by 2-day rest for 4 weeks.


Primary OutcomeTumor reduction 4 weeks after chemoradiotherapy
Secondary OutcomeAdverse events on chemoradiotherapy

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteriaThe cases who have simultaneously another cancer, the cases who have severe complication in their body

Related Information


public contact
Name Hideki Nakayama
Address 1-1-1, Honjyo, Chuo-ku, Kumamoto Japan
Telephone 096-373-5288
Affiliation Graduate School, Kumamoto university Oral & Maxillofacial Surgery
scientific contact
Name Ken Omura
Address 1-5-45, Yushima, Bunkyo-ku, Tokyo Japan
Telephone 03-5803-5506
Affiliation Graduate School, Tokyo Medical and Dental University Oral and Maxillofacial Surgery